Search Within

Howard Scher

  1. "Cell Biology Program Faculty"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Cell Biology Program Faculty (7)
  2. Department of Medicine (7)
  3. Genitourinary Oncology Service (7)
  4. Sloan Kettering Institute Faculty (7)
  5. Solid Tumor Oncology Division (7)
  6. Hematologic Malignancies, Division of (4)

More Groups

People
  1. Malcolm Moore (7)
  2. Alan Yagoda (3)
  3. Ann Jakubowski (3)
  4. Bayard Clarkson (3)
  5. Cora Sternberg (3)
  6. Herbert Oettgen (3)

More People

Years
  1. 1998 (1)
  2. 1997 (1)
  3. 1996 (2)
  4. 1988 (2)
  5. 1987 (1)
Publications
  1. Clinical Cancer Research (2)
  2. Abstracts of Papers of the American Chemical Society (1)
  3. Behring Institut Mitteilungen (1)
  4. Cancer Research (1)
  5. Experimental Hematology (1)
  6. New England Journal of Medicine (1)
Publishers
  1. American Association for Cancer Research (3)
  2. American Chemical Society (1)
  3. Die Medizinische Verlagsgesellschaft Umwelt & Medizin mbH (1)
  4. Elsevier Science, Inc. (1)
  5. Massachusetts Medical Society (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interferon-γ and monoclonal antibody (131)I-labeled CC49: Outcomes in patients with androgen-independent prostate cancer
    Journal Article

    Slovin, S. F.; Scher, H. I.; Divgi, C. R.; Reuter, V.; Sgouros, G.; Moore, M.; Weingard, K.; Pettengall, R.; Imbriaco, M.; El-Shirbiny, A.; more...
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save
  • Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma
    Journal Article

    Engelhardt, M.; Albanell, J.; Drullinsky, P.; Han, W.; Guillem, J.; Scher, H. I.; Reuter, V.; Moore, M. A. S.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save
  • Telomerase activity repression during induced differentiation of human tumor cell lines
    Meeting Abstract

    Albanell, J.; Han, W.; Mellado, B.; Gunawardane, R.; Scher, H. I.; Dmitrovsky, E.; Moore, M. A. S.
    Abstracts of Papers of the American Chemical Society (1996)

    Fulltext@MSK | Save
  • Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines
    Journal Article

    Albanell, J.; Han, W.; Mellado, B.; Gunawardane, R.; Scher, H. I.; Dmitrovsky, E.; Moore, M. A. S.
    Cancer Research (1996)

    Fulltext@MSK | Save
  • Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
    Journal Article

    Gabrilove, J. L.; Jakubowski, A.; Scher, H.; Sternberg, C.; Wong, G.; Grous, J.; Yagoda, A.; Fain, K.; Moore, M. A. S.; Clarkson, B.; more...
    New England Journal of Medicine (1988)

    Fulltext@MSK | Save
  • Recombinant human granulocyte colony stimulating factors: Therapeutic application in the prevention of chemotherapy-induced neutropenia
    Journal Article

    Gabrilove, J. L.; Jakubowski, A.; Scher, H.; Sternberg, C.; Wong, G.; Grous, J.; Yagoda, A.; Fain, K.; Moore, M. A. S.; Clarkson, B.; more...
    Behring Institut Mitteilungen (1988)

    Fulltext@MSK | Save
  • Initial results of a study of recombinant human granulocyte colony stimulating factor (RHG-CSF) in cancer patients
    Meeting Abstract

    Gabrilove, J.; Jakubowski, A.; Grous, J.; Scher, H.; Sternberg, C.; Downing, M.; Alton, K.; Boone, T.; O'Reilly, R.; Moore, M. A. S.; more...
    Experimental Hematology (1987)

    Fulltext@MSK | Save